New processors installed in CUIMC’s High Performance Computing Cluster are designed to give a major boost to AI in biomedical research and analyze increasingly dense and complex biomedical data.
Older adults in England have experienced significant improvements in health compared to previous generations, researchers at Columbia's Robert N. Butler Aging Center have found.
Findings from the Mailman School's HEATE project could inform policy interventions to safeguard the health and well-being of New Yorkers against the threat of extreme indoor temperatures.
Columbia awards the 2024 Louisa Gross Horwitz Prize to Scott Emr and Wesley Sundquist for discovering the ESCRT (Endosomal Sorting Complexes Required for Transport) pathway and revealing how it works.
Established two decades ago, the essential tremor brain bank at Columbia has been instrumental in revealing the source and biology of a common but understudied neurodegenerative disorder.
The center will organize and stimulate research on the human exposome—the cumulative measure of environmental exposures and corresponding biological responses.
Columbia researchers found an increase in surgical sterilization among women after the U.S. Supreme Court overturned the constitutional right to abortion.
The "StreetTalk" method—deployed by Mailman researchers to study energy insecurity—could change the way qualitative research is conducted and publicized while maintaining rigorous standards.
Lewis Silverman, the new director of pediatric hematology, oncology, and stem cell transplantation, is working to minimize the aftereffects of treatment to ensure the highest quality cure possible.
Researchers at Columbia's Mailman School of Public Health found that Florida’s red flag gun law, enacted in 2018, was associated with an 11% reduction in firearm homicide rates from 2019 to 2021.
Gordon has championed the integration of neuroscience and clinical practice, advocating for precision medicine approaches in psychiatry to tailor treatments to individual patients.
At-home tests can detect recent exposure to gluten, but can the tests improve the health of people with celiac disease? Columbia researchers are launching a clinical trial to find out.